EFFECTS OF THE INFUSION OF INSULIN-LIKE GROWTH FACTOR-I IN A CHILD WITH GROWTH-HORMONE INSENSITIVITY SYNDROME (LARON DWARFISM)

被引:127
|
作者
WALKER, JL [1 ]
GINALSKAMALINOWSKA, M [1 ]
ROMER, TE [1 ]
PUCILOWSKA, JB [1 ]
UNDERWOOD, LE [1 ]
机构
[1] CHILD HLTH CTR,DIV ENDOCRINOL,WARSAW,POLAND
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1991年 / 324卷 / 21期
关键词
D O I
10.1056/NEJM199105233242107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THE clinical manifestations of the growth hormone insensitivity syndrome (Laron dwarfism) result from the inability of growth hormone to exert its biologic actions.1,2 Affected children have the severe growth retardation and other physical characteristics of growth hormone deficiency and low serum insulin-like growth factor I (IGF-I) concentrations.1,2 Unlike children with growth hormone deficiency, however, children with growth hormone insensitivity syndrome have high serum growth hormone concentrations, and treatment with growth hormone does not raise their IGF-I concentrations or stimulate growth.1,2 The conclusion that the syndrome is due to abnormal or deficient cellular growth hormone receptors is supported by the finding. © 1991, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:1483 / 1488
页数:6
相关论文
共 50 条
  • [1] STIMULATION OF STATURAL GROWTH BY RECOMBINANT INSULIN-LIKE GROWTH FACTOR-I IN A CHILD WITH GROWTH-HORMONE INSENSITIVITY SYNDROME (LARON TYPE)
    WALKER, JL
    VANWYK, JJ
    UNDERWOOD, LE
    [J]. JOURNAL OF PEDIATRICS, 1992, 121 (04): : 641 - 646
  • [2] THE EFFECT OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-I TREATMENT ON GROWTH-HORMONE SECRETION IN 2 SUBJECTS WITH GROWTH-HORMONE INSENSITIVITY (LARON SYNDROME)
    COTTERILL, AM
    CAMACHOHUBNER, C
    HOLLY, JMP
    SAVAGE, MO
    [J]. CLINICAL ENDOCRINOLOGY, 1993, 39 (01) : 119 - 122
  • [3] EFFECTS OF 17 MONTHS TREATMENT USING RECOMBINANT INSULIN-LIKE GROWTH FACTOR-I IN 2 CHILDREN WITH GROWTH-HORMONE INSENSITIVITY (LARON) SYNDROME
    HEINRICHS, C
    VIS, HL
    BERGMANN, P
    WILTON, P
    BOURGUIGNON, JP
    [J]. CLINICAL ENDOCRINOLOGY, 1993, 38 (06) : 647 - 651
  • [4] EFFECTS OF EXOGENOUS INSULIN-LIKE GROWTH FACTOR-I ON INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS IN A CASE OF GROWTH-HORMONE INSENSITIVITY (LARON-TYPE)
    GOURMELEN, M
    PERIN, L
    BINOUX, M
    [J]. ACTA PAEDIATRICA SCANDINAVICA, 1991, : 115 - 117
  • [5] TISSUES OF THE LARON DWARF ARE SENSITIVE TO INSULIN-LIKE GROWTH FACTOR-I BUT NOT TO GROWTH-HORMONE
    GEFFNER, ME
    GOLDE, DW
    LIPPE, BM
    KAPLAN, SA
    BERSCH, N
    LI, CH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (05): : 1042 - 1046
  • [6] HORMONAL AND METABOLIC EFFECTS AND PHARMACOKINETICS OF RECOMBINANT INSULIN-LIKE GROWTH FACTOR-I IN GROWTH-HORMONE RECEPTOR DEFICIENCY LARON SYNDROME
    VACCARELLO, MA
    DIAMOND, FB
    GUEVARAAGUIRRE, J
    ROSENBLOOM, AL
    FIELDER, PJ
    GARGOSKY, S
    COHEN, P
    WILSON, K
    ROSENFELD, RG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (01): : 273 - 280
  • [8] Effects of insulin-like growth factor-I deficiency and replacement therapy on the hematopoietic system in patients with Laron syndrome (Primary growth hormone insensitivity)
    Sivan, B
    Lilos, P
    Laron, Z
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 (04): : 509 - 520
  • [9] INSULIN-LIKE GROWTH FACTOR-I AND GROWTH-HORMONE IN SHEEP
    PELL, JM
    BLAKE, LA
    BUTTLE, HL
    JOHNSSON, ID
    SIMMONDS, AD
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 1987, 46 (01) : A48 - A48
  • [10] URINARY GROWTH-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I - EFFECTS OF GROWTH-HORMONE INJECTION SCHEDULE
    ALBINI, CH
    QUATTRIN, T
    MILLS, B
    SHERMAN, B
    JOHANSON, A
    MACGILLIVRAY, MH
    [J]. CLINICAL PEDIATRICS, 1992, 31 (09) : 542 - 545